# Proto Labs Inc: overview

PRLB · NYSE · CIK 1443669 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/prlb.md) · [Financials](/companies/prlb/financials.md) · [Filings](/companies/prlb/filings.md) · [Insiders](/companies/prlb/insiders.md)

Latest reported revenue: [$149.3m](/filings/0001443669-26-000035.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 31, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001443669-26-000035).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [126](/filings/0001443669-25-000013.md) | [122 d](/filings/0001443669-26-000010.md) | [126](/filings/0001443669-26-000025.md) | [135](/filings/0001443669-26-000035.md) | [135](/filings/0001443669-25-000013.md) | [136 d](/filings/0001443669-26-000010.md) | [139](/filings/0001443669-26-000025.md) | [149](/filings/0001443669-26-000035.md) |
| Gross margin | % | [45.6%](/filings/0001443669-25-000013.md) | [42.7% d](/filings/0001443669-26-000010.md) | [44.1%](/filings/0001443669-26-000025.md) | [44.3%](/filings/0001443669-26-000035.md) | [45.3%](/filings/0001443669-25-000013.md) | [44.2% d](/filings/0001443669-26-000010.md) | [45.6%](/filings/0001443669-26-000025.md) | [46.4%](/filings/0001443669-26-000035.md) |
| Operating margin | % | [6.8%](/filings/0001443669-25-000013.md) | [(1.2%) d](/filings/0001443669-26-000010.md) | [3.6%](/filings/0001443669-26-000025.md) | [3.7%](/filings/0001443669-26-000035.md) | [6.5%](/filings/0001443669-25-000013.md) | [5.0% d](/filings/0001443669-26-000010.md) | [7.1%](/filings/0001443669-26-000025.md) | [7.6%](/filings/0001443669-26-000035.md) |
| Net margin | % | [5.7%](/filings/0001443669-25-000013.md) | [(0.3%) d](/filings/0001443669-26-000010.md) | [2.9%](/filings/0001443669-26-000035.md) | [3.3%](/filings/0001443669-26-000035.md) | [5.3%](/filings/0001443669-25-000013.md) | [4.4% d](/filings/0001443669-26-000010.md) | [5.8%](/filings/0001443669-26-000035.md) | [6.1%](/filings/0001443669-26-000035.md) |
| Diluted EPS | $ per share | [0.29](/filings/0001443669-25-000013.md) | not reported | [0.15](/filings/0001443669-26-000025.md) | [0.18](/filings/0001443669-26-000035.md) | [0.30](/filings/0001443669-25-000013.md) | not reported | [0.33](/filings/0001443669-26-000025.md) | [0.37](/filings/0001443669-26-000035.md) |
| Free cash flow | $m | [23.2 d](/filings/0001443669-25-000013.md) | [16.5 d](/filings/0001443669-26-000010.md) | [17.1](/filings/0001443669-26-000025.md) | [9.1 d](/filings/0001443669-26-000035.md) | [25.0 d](/filings/0001443669-25-000013.md) | [8.4 d](/filings/0001443669-26-000010.md) | [14.0](/filings/0001443669-26-000025.md) | [9.2 d](/filings/0001443669-26-000035.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [488](/filings/0001628280-24-005285.md) | [488](/filings/0001628280-25-007052.md) | [504](/filings/0001443669-26-000010.md) | [501](/filings/0001443669-26-000010.md) | [533](/filings/0001443669-26-000010.md) |
| Gross margin | % | [45.6%](/filings/0001628280-24-005285.md) | [44.1%](/filings/0001628280-25-007052.md) | [44.1%](/filings/0001443669-26-000010.md) | [44.6%](/filings/0001443669-26-000010.md) | [44.5%](/filings/0001443669-26-000010.md) |
| Operating margin | % | [8.3%](/filings/0001628280-24-005285.md) | [(20.1%)](/filings/0001628280-25-007052.md) | [5.6%](/filings/0001443669-26-000010.md) | [4.0%](/filings/0001443669-26-000010.md) | [4.7%](/filings/0001443669-26-000010.md) |
| Net margin | % | [6.8%](/filings/0001628280-24-005285.md) | [(21.2%)](/filings/0001628280-25-007052.md) | [3.4%](/filings/0001443669-26-000010.md) | [3.3%](/filings/0001443669-26-000010.md) | [4.0%](/filings/0001443669-26-000010.md) |
| Diluted EPS | $ per share | [1.21](/filings/0001628280-24-005285.md) | [(3.77)](/filings/0001628280-25-007052.md) | [0.66](/filings/0001443669-26-000010.md) | [0.66](/filings/0001443669-26-000010.md) | [0.88](/filings/0001443669-26-000010.md) |
| Free cash flow | $m | [21.0](/filings/0001628280-24-005285.md) | [40.4](/filings/0001628280-25-007052.md) | [45.2](/filings/0001443669-26-000010.md) | [68.7](/filings/0001443669-26-000010.md) | [59.7](/filings/0001443669-26-000010.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/prlb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $317.6m | 3,896,222 |  | Added +218,347 |
| [DISCIPLINED GROWTH INVESTORS INC /MN](/funds/1050442.md) | 2026-06-30 | $194.0m | 2,380,514 |  | Reduced −116,841 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $130.4m | 1,599,765 |  | Added +61,235 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $93.9m | 1,152,305 |  | Reduced −120,051 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $92.8m | 1,138,462 |  | Added +46,462 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $86.0m | 1,054,623 |  | Added +14,882 |
| [AMERICAN CAPITAL MANAGEMENT INC](/funds/1320168.md) | 2026-06-30 | $50.5m | 619,845 |  | Reduced −7,860 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $50.1m | 614,028 |  | Added +33,827 |
| [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $38.2m | 469,251 |  | Reduced −51,000 |
| [PRUDENTIAL FINANCIAL INC](/funds/1137774.md) | 2026-06-30 | $37.3m | 457,810 |  | Added +57,569 |

## Recent filings

[All 889 filings](/companies/prlb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 06:06 ET | [8-K](/filings/0001443669-26-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001443669-26-000043 |
| 2026-08-24 | 13:06 ET | [8-K](/filings/0001443669-26-000039.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001443669-26-000039 |
| 2026-07-31 | 15:11 ET | [10-Q](/filings/0001443669-26-000035.md) | Quarterly report, period 2026-06-30 | 0001443669-26-000035 |
| 2026-07-31 | 06:11 ET | [8-K](/filings/0001443669-26-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001443669-26-000034 |
| 2026-05-20 | 15:38 ET | [8-K](/filings/0001443669-26-000028.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001443669-26-000028 |
| 2026-05-07 | 07:51 ET | [8-K](/filings/0001104659-26-056700.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-056700 |
| 2026-05-01 | 13:58 ET | [10-Q](/filings/0001443669-26-000025.md) | Quarterly report, period 2026-03-31 | 0001443669-26-000025 |
| 2026-05-01 | 06:07 ET | [8-K](/filings/0001443669-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001443669-26-000023 |
| 2026-04-08 | 14:15 ET | [DEF 14A](/filings/0001443669-26-000017.md) | Proxy statement, period 2026-05-19 | 0001443669-26-000017 |
| 2026-02-20 | 15:33 ET | [10-K](/filings/0001443669-26-000010.md) | Annual report, period 2025-12-31 | 0001443669-26-000010 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001443669-26-000010.md), filed Feb 20, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/4f9884a3-5e5a-45d5-b03a-0cf4f8391ba2)

## About the filer

- CIK: 1443669
- Tickers: PRLB
- Exchange: NYSE
- SIC code: 3440 Fabricated Structural Metal Products
- State of incorporation: MN
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 14:32 ET. No prices; not investment advice.